These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1736493)

  • 1. Urolithiasis, inhibitors and promoters.
    Grases F; Conte A
    Urol Res; 1992; 20(1):86-8. PubMed ID: 1736493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitors of calcium oxalate crystallization and urolithiasis.
    Grases F; Conte A; Genestar C; Costa-Bauzá A
    Urol Int; 1992; 48(4):409-14. PubMed ID: 1413303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between supersaturation and calcium oxalate crystallization in normals and idiopathic calcium oxalate stone formers.
    Borghi L; Guerra A; Meschi T; Briganti A; Schianchi T; Allegri F; Novarini A
    Kidney Int; 1999 Mar; 55(3):1041-50. PubMed ID: 10027942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Estimation of 24-h excretion of some promotors and inhibitors of crystallization and degree of urine saturation with calcium oxalate in calcium urinary calculi].
    Boruczkowska A
    Pol Arch Med Wewn; 1994 Oct; 92(4):289-98. PubMed ID: 7854956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronopharmacological studies on potassium citrate treatment of oxalocalcic urolithiasis.
    Grases F; Conte A; March JG; García-Ferragut L; Villalonga N
    Int Urol Nephrol; 1997; 29(3):263-73. PubMed ID: 9285296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of overweight and obesity in calcium oxalate stone formation.
    Siener R; Glatz S; Nicolay C; Hesse A
    Obes Res; 2004 Jan; 12(1):106-13. PubMed ID: 14742848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is calcium oxalate nucleation in postprandial urine of males with idiopathic recurrent calcium urolithiasis related to calcium phosphate nucleation and the intensity of stone formation? Studies allowing insight into a possible role of urinary free citrate and protein.
    Schwille PO; Schmiedl A; Manoharan M
    Clin Chem Lab Med; 2004 Mar; 42(3):283-93. PubMed ID: 15080561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simple test to evaluate the risk of urinary calcium stone formation.
    Grases F; García-Ferragut L; Costa-Bauzá A; Conte A; García-Raja A
    Clin Chim Acta; 1997 Jul; 263(1):43-55. PubMed ID: 9247727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measurement of the risk of calcium oxalate crystallization in urine.
    Tiselius HG
    Urol Res; 1985; 13(6):297-300. PubMed ID: 4095829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of urinary macromolecules on the nucleation of calcium oxalate in idiopathic stone formers and healthy controls.
    Borghi L; Meschi T; Guerra A; Bergamaschi E; Mutti A; Novarini A
    Clin Chim Acta; 1995 Jul; 239(1):1-11. PubMed ID: 7586581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative study between etiological factors of calcium oxalate monohydrate and calcium oxalate dihydrate urolithiasis.
    Galán JA; Conte A; Llobera A; Costa-Bauzá A; Grases F
    Urol Int; 1996; 56(2):79-85. PubMed ID: 8659015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcium oxalate urolithiasis in children: urinary promoters/inhibitors and role of their ratios.
    Turudic D; Batinic D; Golubic AT; Lovric M; Milosevic D
    Eur J Pediatr; 2016 Dec; 175(12):1959-1965. PubMed ID: 27730307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zinc, copper and oxalocalcic urolithiasis.
    Grases F; Ruiz J; Costa-Bauzá A; Coll R; Conte A
    Urol Int; 1993; 50(4):205-8. PubMed ID: 8506591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of pH on the risk of calcium oxalate crystallization in urine.
    Berg C; Tiselius HG
    Eur Urol; 1986; 12(1):59-61. PubMed ID: 3948899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystallization of urinary calcium oxalate at standardized osmolality and pH in the frozen state.
    Gohel MD; Shum DK; Li MK
    Clin Chim Acta; 1994 Nov; 231(1):11-22. PubMed ID: 7704943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary inhibitors of calcium oxalate crystallization and their potential role in stone formation.
    Ryall RL
    World J Urol; 1997; 15(3):155-64. PubMed ID: 9228722
    [No Abstract]   [Full Text] [Related]  

  • 17. Role of urinary zinc and copper on calcium oxalate stone formation.
    Ozgurtas T; Yakut G; Gulec M; Serdar M; Kutluay T
    Urol Int; 2004; 72(3):233-6. PubMed ID: 15084769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Idiopathic calcium oxalate urinary lithiasis: usefulness of Parks' and Tiselius' indices in the evaluation of the risk of stone formation.
    Robert M; Roux JO; Boularan AM; Bourelly F; Monnier L; Grasset D
    Urol Int; 1995; 55(2):88-92. PubMed ID: 8533202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crystalluria in idiopathic recurrent calcium urolithiasis. Dependence on stone composition.
    Herrmann U; Schwille PO
    Urol Res; 1992; 20(2):157-64. PubMed ID: 1553791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of proteins that inhibit calcium oxalate crystallization in vitro in the urine of normal and stone-forming individuals.
    Hedgepeth RC; Yang L; Resnick MI; Marengo SR
    Am J Kidney Dis; 2001 Jan; 37(1):104-112. PubMed ID: 11136174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.